Allergeenide ekstraktid
Original notice title
Estonia – Pharmaceutical products – Allergeenide ekstraktid
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
45 / 100
Risk factors
No procurement documents were analyzed; only the notice and XML are available. Critical details (technical specs, ESPD...
All submissions must be in Estonian, which may pose a barrier for international bidders without Estonian language suppo...
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 472k estimated value
- Framework procurement
- Supplies contract
- 1 lot
- Duration 24 MONTH
- Supply of allergen extracts (pharmaceutical products) as detailed in the technical specification (Annex I of the procurement documents).
- Framework agreement for 24 months, open procedure, single operator.
Show full summary
Open tender by Aktsiaselts Ida-Tallinna Keskhaigla for the supply of allergen extracts (pharmaceutical products) under a 24-month framework agreement. The tender covers multiple locations in Estonia, with a total estimated value of €472,000. Submission deadline is 2026-07-16 at 09:00 (EET). Award is based solely on price. Documents are available online, but no detailed eligibility or award criteria beyond price were provided in the analyzed data.
Risks
No procurement documents were analyzed; only the notice and XML are available. Critical details (technical specs, ESPD...
All submissions must be in Estonian, which may pose a barrier for international bidders without Estonian language suppo...
Submission deadline in 9 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Variants not allowed.
Administrative
- Tenders must be submitted electronically via the Estonian e-procurement platform.
- Submission language: Estonian.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Aktsiaselts Ida-Tallinna Keskhaigla
Location
Tallinn, EST
Website
Buyer profile
Identifier
10822068
Activity
Health
Lots (1)
LOT-0000
Allergeenide ekstraktid
Supply of allergen extracts as described in the technical specification. Performance locations include EE001, EE008, EE004, EE00A, EE009 (various Estonian regions). Framework agreement with a single operator, maximum value €472,000.
EUR 472k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Allergeenide ekstraktide ostmine vastavalt RHAD lisas I Tehniline kirjeldus-pakkumuse vorm kirjeldatule. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
Procurement Details
- Publication date
- 15 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Estonian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 410910-2026
Documents (2)
Similar tenders
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Ganirelix (ATC-Code: H01CC01).
Czechia – Pharmaceutical products – Léčivý přípravek ATC skupiny R03DX05 s účinnou látkou OMALIZUMAB
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V über Arzneimittel mit dem Wirkstoff Denosumab Xgeva (ATC-Code nach WHO: M05BX04)
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Formoterol und Beclometason, ausgenommen Dosieraerosole mit der Wirkstärke 100µg/6µg (ATC-Code: R03AK08).
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Moldova – Pharmaceutical products – Achiziționarea centralizată a Reagenților pentru Investigații Clinice, Hematologice și PATOLOGICE conform necesităților IMSP - beneficiari pentru anul 2027
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
45 / 100
Risk factors
No procurement documents were analyzed; only the notice and XML are available. Critical details (technical specs, ESPD...
All submissions must be in Estonian, which may pose a barrier for international bidders without Estonian language suppo...
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications